Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adults

Key Inclusion Criteria

• Capable of giving signed informed consent and comply with the requirements listed in the Informed Consent Form.
• Willing and able to follow all instructions and attend all study visits.
• History of redness relief eyedrop use within the last 6 months, or an interest in using over-the-counter redness relief drops, or would benefit from the use of redness relief drops in the investigator's opinion.
• Baseline investigator-assessed ocular redness score of 0.5 or higher in at least one eye at Visit 1 when applicable and a score of greater than 1.0 in both eyes on a 5-point scale prior to randomization on Day 1 (Visit 2).
• Other protocol-defined inclusion criteria may apply.

Key Exclusion Criteria

• Known contraindications or sensitivity to the use of any of the investigational product(s) or their components, or any other medication required by the protocol.
• Ocular surgical intervention within 6 months prior to Visit 1 or during the study.
• Any ocular condition that, in the opinion of the investigator, may compromise the subject's safety or study specific parameters.
• Use of any of the prohibited medications or devices as specified in the study protocol.
• Out-of-range vital signs (blood pressure and/or pulse rate) as defined in the study protocol.
• Abnormal intraocular pressure.
• Other protocol-defined exclusion criteria may apply.